Changeflow GovPing Healthcare & Life Sciences Lung Biotechnology PBC Cell Scaffold Patent App...
Routine Notice Added Final

Lung Biotechnology PBC Cell Scaffold Patent Application US20260109952A1

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

Lung Biotechnology PBC has filed US Patent Application US20260109952A1, published April 23, 2026, for a printable composition used to manufacture cell-receiving scaffolds. The composition comprises approximately 0.3 to 3.0 wt% collagen, 5.0 to 40.0 wt% monomers, 0.5 to 2.0 wt% photoinitiator, and up to 75 wt% protic solvent vehicle. The application claims a printing resolution of 100 microns or less, specific photo speed parameters (Dp/Ec of 0.1-5 mm Dp and 10-100 mJ/cm² Ec), and a green strength of at least 5 kPa after drying. The patent also covers methods for manufacturing three-dimensional cell-receiving scaffolds using the composition. Inventors include Pingyong Xu, Luis Alvarez, Derek Morris, and Iman Yazdi, with filing date December 10, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 227 changes logged to date.

What changed

US Patent Application US20260109952A1 was published by the USPTO on April 23, 2026, disclosing Lung Biotechnology PBC's printable composition for manufacturing cell-receiving scaffolds. The application specifies compositional ranges including 0.3-3.0 wt% collagen, 5.0-40.0 wt% monomers, 0.5-2.0 wt% photoinitiator, and up to 75 wt% protic solvent vehicle, along with claimed performance metrics of 100-micron-or-less resolution and at least 5 kPa green strength. The scope includes both the printable composition and methods for manufacturing three-dimensional scaffolds.

Competitors in the bioprinting, tissue engineering, or regenerative medicine scaffold space should monitor this application for potential overlap with their own IP portfolios or freedom-to-operate concerns. The published application provides a detailed technical disclosure that may inform competitive R&D or alternative design approaches.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD

Application US20260109952A1 Kind: A1 Apr 23, 2026

Assignee

Lung Biotechnology PBC

Inventors

Pingyong Xu, Luis Alvarez, Derek Morris, Iman Yazdi

Abstract

A printable composition for the manufacture of cell-receiving scaffolds comprising about 0.3 wt % to about 3.0 wt % of one or more collagens; about 5.0 wt % to about 40.0 wt % of one or more monomers; about 0.5 wt % to about 2.0 wt % of a photo initiator; and 0 wt % to about 75 wt % of a vehicle comprising a protic solvent, by weight of the printable composition; wherein the printable composition has a resolution of about 100 microns or less when printed, a photo speed (Dp/Ec) of about 0.1-5 mm (Dp) and about 10-100 mJ/cm2 (Ec) when printed, and a green strength of at least about 5 kPa after drying. The present technology further includes methods of manufacturing a three-dimensional cell-receiving scaffold using the printable composition.

CPC Classifications

C12N 5/0693 B29C 64/124 B33Y 10/00 B33Y 70/00 B29K 2105/0002 B29L 2031/7532 B33Y 80/00 C12N 2533/54

Filing Date

2025-12-10

Application No.

19414664

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Manufacturers Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent application filing Bioprinting materials Scaffold manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!